Approval · Notice of Compliance 18472 · 2016
PREFESTA: Notice of Compliance 18472
Issued September 2, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18472
- Date
- September 2, 2016
- Company
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety and formatting updates to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREFESTA | 02247906 | Cancelled Pre Market |
Medicinal ingredients
- ESTRADIOL 1 MG per TAB
- NORGESTIMATE 90 MCG per TAB